MBF-118
MBF-118 is a potent and selective covalent partial agonist of the PPARγ nuclear receptor as a potential therapy for fibrosis in Crohn’s disease.
MBF-362
MBF-362 is an antagonist of the prostaglandin EP4 receptor as a novel immunotherapy for cancer treatment.
MBF-015
MBF-015 is a novel and selective histone deacetylase 1/2 inhibitor as a potential disease modifying therapy for synaptic loss in neurodegenerative diseases.